NCT06570915 2025-10-01T-ALL-2024Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2 Not yet recruiting20 enrolled
NCT03384654 2025-05-25A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaJanssen Research & Development, LLCPhase 2 Completed47 enrolled 22 charts